s-disease

Documents about s-disease

• Dexmedetomidine Exerts Multi-Level Effects to Ameliorate Alzheimer’s Disease Pathology in the Adult Zebrafish Brain#256625İzmir Yüksek Teknoloji Enstitüsü
• An automated plasma‐based proteotyping immunoassay for APOE ε4 zygosity classification in Alzheimer's disease#274386HAL (France)
• The Role of Verbal Memory in Masking Symptoms of Alzheimer's Disease#13909bioRxiv / medRxiv
• Restoring Theta–Gamma coupling in Alzheimer's disease: Toward network-based neuromodulation.#30688NCBI PubMed Central
• The YTHDF proteins shape the brain gene signatures of Alzheimer's disease#290724bioRxiv / medRxiv
• Alzheimer’s Disease Brain Phenotypes are Age-dependent#5466Europe PMC
• Integrating the physical environment into Alzheimer's disease and Alzheimer's disease related dementias research: A Gateway Exposome Coordinating Center (GECC) agenda on gaps and priorities.#125276NCBI PubMed Central
• Dopaminergic Identity of SH-SY5Y Cells Across Differentiation Protocols in Parkinson's Disease Research: A Systematic Review#205518Europe PMC
• Bio-inspired Solid Lipid Nanoparticles for therapeutic siRNA delivery targeting the LRRK2 G2019S mutation in a Parkinson’s disease cell model.#215983ResearchSpace
• Effects of physical exercise on cognitive impairment in patients with Alzheimer's disease, Parkinson's disease or mild cognitive impairment: a systematic review and meta-analysis.#288888NCBI PubMed Central
• Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease#125955ClinicalTrials.gov
• Destination and source memory in Huntington's disease#157674HAL (France)
• Parkinson’s Disease and Its Treatments: An Overview#191324Scholars Crossing
• Interpretable deep survival analysis of Alzheimer's disease via metabolic genetic variants.#251014NCBI PubMed Central
• Expression of GPR34 in microglia remains stable in human Alzheimer's disease.#284899NCBI PubMed Central
• Overcoming the blood‒brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease#4528Europe PMC
• Integrating Eye Tracking and Inertial Sensing for Enhanced Freezing of Gait Detection in Parkinson's Disease#5577Europe PMC
• Cortically Mediated Muscle Responses to Balance Perturbations Increase with Perturbation Magnitude in Older Adults with and without Parkinson's Disease#5585Europe PMC
• Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer’s disease model#14159HAL (France)
• Molecular neuroimaging of Parkinson's disease: association of motor and non-motor symptoms with synaptic density, dopaminergic and serotonergic systems#120101Europe PMC
• Divergent patterns of cognitive decline in preclinical Alzheimer's disease: Implications for secondary prevention trials#125782Europe PMC
• The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn’s Disease#185490IRIS
• Neuroimaging in dementia and Alzheimer's disease: Current protocols and practice in the Republic of Ireland#186496Research Repository UCD
• Increased beta-HFO phase-amplitude coupling in the subthalamic nucleus during movement in Parkinson's disease#234998Europe PMC
• Reproductive factors and clinical features of Parkinson's disease#288359IRIS
• A Bioinformatic Analysis of BAG Protein Interactors and Pathways in Alzheimer's and Parkinson's Disease.#154199NCBI PubMed Central
• Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease#172431ClinicalTrials.gov
• Myeloid-Driven Inflammation in Prodromal Parkinson's Disease#180151bioRxiv / medRxiv
• Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)#250617IRIS
• Baseline FDG-PET Brain hypometabolism as a predictive biomarker of cognitive decline and Alzheimer's disease risk#182055Europe PMC
• Comparative Analysis of Deep Learning Techniques in Alzheimer's Disease Diagnosis: Trends, Challenges, and Future Directions#205465Europe PMC
• Selective reduction of KCNA4 in vulnerable glutamatergic-serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease#212948Europe PMC
• The impact of the interaction between SIRT1 and lifestyle factors on Alzheimer’s disease risk and related phenotypes#223394Research Online
• System changes to empower primary care in Alzheimer's disease detection and care.#143063NCBI PubMed Central
• Presymptomatic plasma biomarkers in autosomal dominant Alzheimer's disease: sequence and timing#143862bioRxiv / medRxiv
• Alpha rhythm and Alzheimer's disease: Has Hans Berger's dream come true?#154483NCBI PubMed Central
• Guideline review: 2025 British Society of Gastroenterology guidelines on inflammatory bowel disease in adults – Part 1: Crohn’s disease#276048PubMed Central
• HyCoSwin-PD: An explainable hybrid ConvNeXtV2-Swin transformer framework for Parkinson's disease detection from neuroimaging#5355Europe PMC
• Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzheimer's disease via computational screening and experimental validation#5503Europe PMC
• Physical Exercise and Mechanism Related to Alzheimer’s Disease: Is Gut–Brain Axis Involved?#197444Repositorio UNAB
• Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer’s Disease Model#231289Europe PMC
• Transcriptional regulation of α-synuclein by TRIM17, TRIM41 and ZSCAN21 pathway in Parkinson’s disease#231574HAL (France)
• Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.#148152NCBI PubMed Central
• Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease#148864bioRxiv / medRxiv
• Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's#158073ClinicalTrials.gov
• Poor sleep quality correlates with axial symptoms and mood problems in Parkinson's disease.#284905NCBI PubMed Central
• Engineering nanobodies for drug delivery systems in Alzheimer's disease.#9730PubMed
• Using explainable AI to identify disease-relevant and deep brain stimulation treatment-sensitive gait features in Parkinson's disease.#275523NCBI PubMed Central
• Mapping individual molecular connectomes in Alzheimer's disease.#123051NCBI PubMed Central
• Fragile polyQ assemblies cause Golgipathy in Huntington's disease#183313bioRxiv / medRxiv